Navigation auf uzh.ch
Navigation auf uzh.ch
Meling D, Scheidegger M. Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective. Front Psychol. 2023 Apr 3;14:1100058. doi: 10.3389/fpsyg.2023.1100058.
Bouso JC, Andión Ó, Sarris JJ, Scheidegger M, Tófoli LF, Opaleye ES, Schubert V, Perkins D. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob Public Health. 2022 Nov 16;2(11):e0000438. doi: 10.1371/journal.pgph.0000438.
Langlitz N, Dyck E, Scheidegger M, Repantis D. Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics. Front Psychiatry. 2021 Aug 2;12:680064. doi: 10.3389/fpsyt.2021.680064.
Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. Molecules. 2021 Apr 22;26(9):2451. doi: 10.3390/molecules26092451.
Scheidegger M. Comparative phenomenology and neurobiology of meditative and psychedelic states of consciousness: Implications for psychedelic-assisted therapy. In: Grob CS, Grigsby J (eds.): Handbook of Medical Hallucinogens. New York: Guilford Press. 2021; 395-413. https://psycnet.apa.org/record/2021-12666-021
Scheidegger M. Psychedelic Medicines: A Paradigm Shift from Pharmacological Substitution Towards Transformation-Based Psychiatry. In: Labate BC, Cavnar C (eds): Ayahuasca Healing and Science. Cham: Springer. 2021; 43-61. https://doi.org/10.1007/978-3-030-55688-4_3
Smigielski L, Kometer M, Scheidegger M, Krähenmann R, Huber T, Vollenweider FX. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Sci Rep. 2019 Oct 24;9(1):14914. doi: 10.1038/s41598-019-50612-3
Smigielski L, Scheidegger M, Kometer M, Vollenweider FX. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Neuroimage. 2019 Aug 1;196:207-215. doi:10.1016/j.neuroimage.2019.04.009.
Gärtner M, Aust S, Bajbouj M, Fan Y, Wingenfeld K, Otte C, Heuser-Collier I, Böker H, Hättenschwiler J, Seifritz E, Grimm S, Scheidegger M. Functional connectivity between prefrontal cortex and subgenual cingulate predicts antidepressant effects of ketamine. Eur Neuropsychopharmacol. 2019 Apr;29(4):501-508. doi:10.1016/j.euroneuro.2019.02.008.
Jungaberle H, Thal S, Zeuch A, Rougemont-Bücking A, von Heyden M, Aicher H, Scheidegger M. Positive psychology in the investigation of psychedelics and entactogens: A critical review. Neuropharmacology. 2018 Nov;142:179-199. doi:10.1016/j.neuropharm.2018.06.034.
